Sign in or create a free account to view this dataset's chart and data table.
Key Takeaway
- Genitourinary system medicines recorded a CAGR of 3% between FY 2019–20 and FY 2024–25, indicating moderate growth. Products include diuretics, acidifiers, alkalinisers and uterine or vaginal acting agents. The category expanded at a slower pace than immunotherapy, cardiovascular and central nervous system medicines.
About This Dataset
Annual sales data for animal health genitourinary medicines, including diuretics, acidifiers, alkalinisers and uterine or vaginal acting agents. These products are used in the management of urinary, reproductive and related physiological conditions in animals. The dataset provides aggregated sales by financial year from 1 July to 30 June.
Methodology
Sign in or create a free account to view this dataset's methodology and sources.
Available formats: Excel, CSV, PNG, PDF.
Transform Data Into Better Business Decisions
Join organizations that rely on statSCALAR for trusted market intelligence, industry statistics, commodity insights and enterprise research.